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Abstract Nitric oxide (NO) reversibly inhibited oxygen consumption of brain synaptosomes. Inhibition was reversible, occurred at the level of 
cytochrome oxidase, and was apparently competitive with oxygen, with half-inhibition by 270 nM NO at oxygen concentrations around 145 PM and 
by 60 nM NO at around 30 PM Oz. Isolated cytochrome oxidase was inhibited by similar levels of NO. These levels of NO are within the measured 
physiological and pathological range for a number of tissues and conditions, suggesting that NO inhibition of cytochrome oxidase and the competion 
with oxygen may occur in vivo. 
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1. Introduction 
Nitric oxide (NO) is a free-radical gas which acts as: (a) an 
intercellular messenger; and (b) a cytotoxic agent in some con- 
ditions (reviewed in [l-3]). NO produced by the endothelium 
is involved in the normal regulation of blood flow in many 
tissues. NO produced post-synaptically by some neurons may 
be involved in changing synaptic efficiency during memory 
formation in the brain. During infection/injury NO produced 
by a range of cells, including macrophages, may have protective 
and/or toxic roles. NO is toxic to many cell types at various 
levels. The mechanism of NO toxicity is unclear, but is thought 
to include damage to: mitochondrial complexes I and II, mito- 
chondrial aconitase, glyceraldehyde-3-phosphate dehydroge- 
nase, ribonucleotide reductase, and DNA [4]. NO levels may 
increase dramatically during ischaemia and/or reperfusion in 
brain [S], and inhibitors of nitric oxide synthase may protect 
against subsequent damage [2]. The neurotoxicity of glutamate 
has been suggested to be mediated partly by NO [ 1,2]. 
Because the cytotoxic effects of NO have been suggested to 
be exerted partly on mitochondrial respiration, we tested the 
effects of NO on the respiration of isolated nerve terminals 
(synaptosomes) from rat brain. 
2. Materials and methods 
Synaptosomes were isolated from whole brain of 3-week-old rats as 
in [6]. Isolated synaptosomes were incubated at 1 mg protein/ml in 125 
mM NaCI, 15 mM HEPES, 10 mM glucose, 6 mM KCI, 5 mM Na- 
pyruvate, 1.2 mM MgSO,, 1 mM NaHPO,, 1 mM CaCl,, 250 nM 
FCCP (carbonyl cyanidep-trifluoromethoxyphenylhydrezone, a mito- 
chondrial uncoupler), at pH 7.2. Incubations were in a stirred sealed 
vessel thermostated at 25“C, with an oxygen electrode (Rank Brothers) 
and Clark-type nitric oxide-selective electrode (World Precision Instru- 
ments; based on Shibuki, 1990) inserted through a gas-tight port at the 
top of the vessel. The NO electrode was calibrated bv two indeuendent 
methods. In the first method an aliquot of NO-saturated water of 
known NO concentration (see below) was injected into the stirred vessel 
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when the vessel was anaerobic, to give a known NO concentration. In 
the second method a known amount of potassium nitrite was injected 
into a stirred, anaerobic vessel containing KI, H,SO,, and K,SOI to 
release stoichiometric NO (as in [8]). The two different calibrations gave 
the same NO-electrode response/sensitivity to within 10%. Oxygen had 
no detectable ffect on the NO electrode, and NO had no detectable 
effect on the oxygen electrode. The oxygen consumption rates were 
corrected for a low rate of oxygen diffusion into the vessel, by adding 
cyanide or rotenone at the end of the experiment and following the rate 
of oxygen diffusion into the vessel. 
In experiments with sodium nitroprusside (Fluka) NO release was 
caused by the addition of light. Light was sunnlied bv a 150 W domestic 
light bulb at 10 cm from theincubition vess& the light passing through 
two holes in a box so that the light only fell on the incubation chamber. 
Daylight caused significant release of NO from nitroprusside, so all 
extraneous light was excluded. Nitroprusside was made up fresh on the 
day and protected from light. In experiments with NO gas, oxygen was 
removed from a test tube of distilled water by bubbling with oxygen- 
free nitrogen gas. This was then bubbled with pure NO gas (BDW 
Merck) to saturate with NO, and then sealed with a rubber seal. The 
concentration of NO in NO-saturated water was taken as 2.0 mM at 
20°C [9]. 
Cytochrome oxidase was isolated by the method of Kuboyama et al. 
[lo] with Tween-80 substituting for Emasol and incubated at 100 nM 
in 100 mM potassium phosphate @H 7.0), 5 mM sodium ascorbate, 
0.42 mM TMPD (N.N.W,N-tetramethyl-p-phenylenediamin e dihy- 
drochloride) 0.1% n-dodecyl p-n-maltoside, and 10 PM cytochrome c, 
at 25’C. 
3. Results 
We tested the effect of NO on synaptosomal respiration by 
measuring oxygen consumption and NO levels simultaneously, 
and adding either NO gas or nitroprusside. NO is released from 
nitroprusside when photolysed by light [l 11. Fig. 1 shows that 
exposure to light in the presence of nitroprusside caused contin- 
uously increasing levels of NO, and increasing inhibition of the 
respiration rate. Turning the light off caused the NO level to 
decay, and the respiration rate was reactivated with the same 
time course as the decay of the NO level. Subsequent addition 
of light caused more NO release and inhibition of respiration, 
but (a) more NO was released for the equivalent exposure to 
light when the concentration of oxygen was lower, and 
(b) equivalent levels of NO caused higher levels of inhibition 
when the concentration of oxygen was lower. Half-inhibition 
of respiration rate occurred at about 250 nM NO at 130 PM 
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Fig. 1. Light activated NO release from nitroprusside causes reversible inhibition of synaptosomal 
indicated in section 2 with an oxygen electrode (upper trace) and NO electrode (lower trace). 
respiration. Synaptosomes were incubated as 
0,. The correlation between the levels of nitric oxide and inhi- 
bition during and after light suggests that the inhibitory agent 
is nitric oxide itself, and that the inhibition is rapid and revers- 
ible. The inhibition of respiration in the light was completely 
prevented by the presence of 15 ,uM haemoglobin (Sigma; unde- 
fined redox state). Since haemoglobin avidly binds NO and 
oxyhemoglobin inactivates NO [9], this finding again suggests 
that the inhibitory agent is NO. In order to determine where 
within the synaptosomal metabolism the NO was inhibiting 
respiration, we looked at the effect of NO release on the optical 
spectrum of the synaptosomes. The spectrum was recorded (in 
an Aminco DW-2000 scanning spectrophotometer) prior to 
and immediately after exposure to the light source in the pres- 
ence of nitroprusside, and the difference spectrum is repro- 
duced in Fig. 2. Exposure to light causes a clear reduction of 
cytochrome a (difference peak at 605 nm) and cytochrome c 
(difference peak at 550 nm). Since the synaptosomes were fully 
uncoupled the reduction can only be caused by an inhibition 
at cytochrome oxidase on the oxygen side of the a cytochromes. 
We also used water saturated with NO (sometimes referred 
to as ‘authentic’ NO), prepared by bubbling pure NO gas 
through distilled water previously purged with oxygen-free 
nitrogen. Addition of this NO to the synaptosomal incubation 
caused immediate inhibition of respiration, which reversed as 
the NO was degraded (not shown). The dependence of respira- 
tion rate on NO level during the decay is plotted in Fig. 3, and 
was used to determine the Ki for NO. This was repeated at a 
lower oxygen concentration range by bubbling the incubation 
medium with oxygen-free nitrogen prior to addition of the 
synaptosomes. Fig. 3 shows that at an approximately S-fold 
lower concentration of oxygen, an approximately S-fold lower 
concentration of NO is required to half-inhibit respiration. The 
K, was estimated to be 270 nM NO when the oxygen concentra- 
tion was between 125 and 165 PM O,, and 60 nM NO when 
the oxygen concentration was 18-38 ,uM 0,. This indicates that 
NO competes with oxygen, and suggests that the sight of inhi- 
bition is at the oxygen binding sight of cytochrome oxidase. 
Measurement of the optical spectrum of the synaptosomal in- 
cubation before and immediately after addition of NO gave a 
difference spectrum similar to that for nitroprusside and light, 
confirming that NO inhibits respiration at cytochrome oxidase 
on the oxygen side of cytochrome a. 
The effect of NO on isolated cytochrome oxidase (purified 
from beef heart) was also measured (see Fig. 4). The addition 
of NO caused rapid and reversible inhibition of cytochrome 
oxidase at concentrations of NO similar to those causing inhi- 
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Fig. 2. Light-activated NO release from nitroprusside causes reduction 
of cytochromes a and c in synaptosomes. The spectra of incubated 
synaptosomes was recorded before and immediately after light in the 
presence of nitroprusside, and the difference spectrum is given above 
(after-before). 
bition of synaptosomal respiration (half inhibition of oxygen 
consumption rate by 250 nM NO at 145 ,uM 0,). 
4. Discussion 
The results show that low levels of NO cause reversible inhi- 
bition of cytochrome oxidase probably in competition with 
oxygen. This is not entirely surprising as it has long been known 
that NO binds tightly to the reduced form of cytochrome oxi- 
dase at the oxygen binding site [12]. And it has been noted that 
the NGcytochrome oxidase complex is unstable in the pres- 
ence of oxygen [ 131, although this is probably due to the debind- 
ing of NO and reaction with oxygen. However the effects of NO 
on the steady-state kinetics of cytochrome oxidase in the pres- 
ence of oxygen have not been investigated until recently. 
Cleeter et al. [14] have reported that an NO generator S-nitro- 
soglutathione reversibly inhibits respiration of isolated mito- 
chondria from skeletal muscle at cytochrome oxidase. However 
the levels of NO, and the type of inhibition were not investi- 
gated. NO has been reported to inhibit mitochondrial aconi- 
tase, and complexes I and II of the respiratory chain in a 
manner which is only slowly reversible [4,15,16]. However, the 
concentrations of NO required for this type of inhibition are 
about lOOO-fold higher than those used here. Bolafios et al. [ 171 
have recently shown that cultured astrocytes induced to pro- 
duce NO at high rates have decreased activity of cytochrome 
oxidase. But this was apparently irreversible damage caused by 
long-term exposure to NO. 
We measured the Ki of NO for respiration to be 270 nM NO 
at 145 ,uM 0, (a typical O2 concentration for arterial blood) and 
60 nM NO at 30 ,uM O2 (a typical 0, concentration for tissues). 
How does this compare with levels of NO produced by cells and 
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Fig. 3. Relation between NO level and inhibition of synaptosomal 
respiration at two different levels of oxygen. NO-saturated water was 
added to the synaptosomal incubation at two different levels of oxygen. 
The dependence of the respiration rate on the measured concentration 
of NO during the decay of the NO level is plotted for two different 
incubations at each oxygen level. The ranges of oxygen concentrations 
were 125-165 PM 0, (a,~) and 18-38 PM 0, (u,#. 
Fig. 4. Inhibition of isolated cytochrome oxidase by NO-saturated 
water. 100 nM cytochrome oxidase was added, followed by 1 ,uM NO, 
and when the system became anaerobic (oxygen trace flattens off) a 
further 1 PM NO was added to calibrate the electrode. 
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tissues? Reported levels measured by NO-electrode are: up to 
1300 nM NO in bradykinin-stimulated aorta [ 18,191, 100-500 
nM NO outside cultured endothelial cells [8], up to 500 nM NO 
from collagen-stimulated platelets in whole blood [20], and a 50 
nM NO increase during electrical stimulation of brain cerebel- 
lar slices [7,21]. These levels suggest hat the NO inhibition of 
cytochrome oxidase may be significant in some physiological 
conditions, and if so NO could be the first known physiological 
regulator to act directly on the mitochondrial respiratory chain 
[22]. In whole brain in vivo NO levels have been measured by 
electrode to be ~10 nM in the basal state, 10004000 nM ini- 
tially during ischaemia, declining in late ischaemia and then 
rising to about 1000 nM during reperfusion [5]. Tissue NO 
levels are also thought to be high after endotoxin/cytokine 
induction of the inducible form of NO synthase, but have not 
been measured as yet. 200-800 nM NO has been shown to 
inhibit gluconeogenesis and protein synthesis in hepatocytes 
[23], and this inhibition might well be mediated by NO inhibi- 
tion of cytochrome oxidase. 
The competition between NO and oxygen for cytochrome 
oxidase has one other important implication: if nanomolar NO 
is present in tissues the apparent K,,, for oxygen of respiration 
in these tissues will be much higher than in isolated cytochrome 
oxidase or mitochondria in the absence of NO. In fact the 
apparent K, for oxygen in a range of tissues has been measured 
to be much higher than to be expected from the in vitro K,,, (see 
PWW. 
A number of explanations for this phenomenon have been 
suggested, but it is possible that tissue NO might contribute to 
raising the K, for oxygen. 
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